Analysts Set Definitive Healthcare Corp. (NASDAQ:DH) Target Price at $11.31

Definitive Healthcare Corp. (NASDAQ:DHGet Free Report) has been assigned an average recommendation of “Hold” from the ten brokerages that are presently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $11.31.

DH has been the topic of a number of research analyst reports. Barclays boosted their price objective on shares of Definitive Healthcare from $10.00 to $11.00 and gave the company an “equal weight” rating in a research report on Friday, March 1st. Canaccord Genuity Group boosted their price objective on shares of Definitive Healthcare from $9.00 to $10.00 and gave the company a “hold” rating in a research report on Thursday, February 29th. Canaccord Genuity Group downgraded shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Needham & Company LLC downgraded shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, January 17th. Finally, Stifel Nicolaus reduced their price objective on shares of Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Wednesday, January 17th.

Check Out Our Latest Stock Analysis on Definitive Healthcare

Hedge Funds Weigh In On Definitive Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in shares of Definitive Healthcare by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 4,468,309 shares of the company’s stock worth $44,415,000 after purchasing an additional 136,766 shares during the period. Virtu Financial LLC bought a new position in shares of Definitive Healthcare in the 4th quarter worth approximately $111,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Definitive Healthcare by 12.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,004 shares of the company’s stock worth $120,000 after purchasing an additional 1,332 shares during the period. Townsquare Capital LLC bought a new position in shares of Definitive Healthcare in the 4th quarter worth approximately $130,000. Finally, Barclays PLC lifted its stake in shares of Definitive Healthcare by 367.2% in the 4th quarter. Barclays PLC now owns 73,748 shares of the company’s stock worth $733,000 after purchasing an additional 57,963 shares during the period. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Trading Up 2.0 %

DH stock opened at $8.07 on Friday. The company has a market capitalization of $950.00 million, a PE ratio of -4.53, a price-to-earnings-growth ratio of 7.40 and a beta of 1.43. Definitive Healthcare has a one year low of $5.53 and a one year high of $12.45. The company’s 50 day moving average price is $8.77 and its two-hundred day moving average price is $8.34. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31.

Definitive Healthcare (NASDAQ:DHGet Free Report) last issued its earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The firm had revenue of $65.93 million during the quarter, compared to the consensus estimate of $66.01 million. As a group, analysts predict that Definitive Healthcare will post 0.11 earnings per share for the current fiscal year.

Definitive Healthcare Company Profile

(Get Free Report

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Featured Stories

Analyst Recommendations for Definitive Healthcare (NASDAQ:DH)

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.